Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals

This publication has 37 references indexed in Scilit:

• Extended-Spectrum β-Lactamases in Enterobacteriaceae in Buenos Aires, Argentina, Public Hospitals
  Antimicrobial Agents and Chemotherapy, 2003
• Clinical Isolates of Enterobacteriaceae Producing Extended-Spectrum β-Lactamases: Prevalence of CTX-M-3 at a Hospital in China
  Antimicrobial Agents and Chemotherapy, 2003
• Broad Resistance Due to Plasmid‐Mediated AmpC β‐Lactamases in Clinical Isolates ofEscherichia coli
  Clinical Infectious Diseases, 2002
• Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998–99)
  Diagnostic Microbiology and Infectious Disease, 2002
• CTX-M-3β-Lactamase-ProducingEscherichia colifrom Greece
  Microbial Drug Resistance, 2002
• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
  Clinical Microbiology Reviews, 2001
• Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest method
  Diagnostic Microbiology and Infectious Disease, 1999
• Emergence of Ciprofloxacin Resistance in Escherichia coli Isolates after Widespread Use of Fluoroquinolones
  Diagnostic Microbiology and Infectious Disease, 1998
• Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the etest method
  Diagnostic Microbiology and Infectious Disease, 1997
• The Use of Analytical Isoelectric Focusing for Detection and Identification of -Lactamases
  Journal of General Microbiology, 1975